Treatment of rats with glucagon, vasointestinal peptide or secretin has a different effect on bilirubin and p-nitrophenol UDP-glucuronyltransferase

The aim of the present study was to investigate whether vasoactive intestinal peptide (VIP) also has an effect on glucuronidation and whether glucagon and VIP, both belonging to the secretin family of polypeptides, have a specificity for the acceptor substrate used.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Biochemical pharmacology 1988-09, Vol.37 (18), p.3526-3528
Hauptverfasser:	Ricci, G.L., Fevery, J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Bilirubin - metabolism Biological and medical sciences Gastroenterology. Liver. Pancreas. Abdomen glucagon Glucagon - pharmacology Glucuronosyltransferase - analysis Male Medical sciences Nitrophenols - metabolism Rats Rats, Inbred Strains secretin Secretin - pharmacology vasoactive intestinal peptide Vasoactive Intestinal Peptide - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The aim of the present study was to investigate whether vasoactive intestinal peptide (VIP) also has an effect on glucuronidation and whether glucagon and VIP, both belonging to the secretin family of polypeptides, have a specificity for the acceptor substrate used.
ISSN:	0006-2952 1873-2968
DOI:	10.1016/0006-2952(88)90707-1